Purple Biotech Ltd (TLV:PPBT)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1.000
0.00 (0.00%)
At close: Mar 11, 2026

Purple Biotech Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
8.727.414.4915.0310.89
Short-Term Investments
0.861.120.9217.0836.31
Cash & Short-Term Investments
9.578.5215.4132.1147.2
Cash Growth
12.32%-44.69%-52.01%-31.96%-18.35%
Prepaid Expenses
-0.280.2111.01
Other Current Assets
0.290.110.170.150.27
Total Current Assets
9.878.9115.7933.2648.47
Property, Plant & Equipment
0.350.290.470.680.9
Long-Term Investments
----0.19
Other Intangible Assets
7.3627.8428.0420.6820.48
Other Long-Term Assets
----0.16
Total Assets
17.5737.0444.354.6270.2
Accounts Payable
2.071.463.532.131.47
Accrued Expenses
-1.23.464.722.56
Current Portion of Leases
0.240.180.190.190.2
Other Current Liabilities
5.441.152.520.010.02
Total Current Liabilities
7.753.999.77.064.25
Long-Term Leases
--0.160.320.55
Pension & Post-Retirement Benefits
0.160.140.140.150.29
Total Liabilities
7.914.1310.017.525.09
Additional Paid-In Capital
152.48147.63133.18126.41123.95
Retained Earnings
-171.08-144.69-137.45-117.57-95.91
Comprehensive Income & Other
28.3129.9238.4838.0836.78
Total Common Equity
9.7132.8634.2146.9164.83
Minority Interest
-0.060.050.090.190.28
Shareholders' Equity
9.6632.9134.347.165.11
Total Liabilities & Equity
17.5737.0444.354.6270.2
Total Debt
0.240.180.350.520.75
Net Cash (Debt)
9.338.3415.0631.646.45
Net Cash Growth
11.86%-44.62%-52.34%-31.98%-18.38%
Net Cash Per Share
0.010.030.070.170.26
Filing Date Shares Outstanding
2,382529.64265.58207.87178.26
Total Common Shares Outstanding
2,382517.13252.38184.82178
Working Capital
2.114.926.0926.244.22
Book Value Per Share
0.000.060.140.250.36
Tangible Book Value
2.355.026.1626.2344.35
Tangible Book Value Per Share
0.000.010.020.140.25
Source: S&P Global Market Intelligence. Standard template. Financial Sources.